Table 3.
Results for Stroke Recurrence (Upper Diagonal Part) and Intracranial Hemorrhage (Lower Diagonal Part) From Network Meta-Analyses
| Treatment | Asp | Cilo | Clop | Dip | Sarp | Teru | Tic | Trif | Asp+Clop | Asp+Dip | Asp+Tic |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asp | 1.00 | 0.66 (0.44 to 0.92)* | 0.89 (0.72 to 1.14) | 1.13 (0.80 to 1.54) | 1.19 (0.69 to 1.87) | 1.04 (0.72 to 1.44) | 0.87 (0.65 to 1.10) | 0.98 (0.68 to 1.37) | 0.85 (0.68 to 1.09) | 0.89 (0.74 to 1.06) | 1.45 (0.40 to 3.78) |
| Cilo | 0.27 (0.08 to 0.58)* | 1.00 | 1.39 (0.91 to 2.16) | 1.77 (1.06 to 2.94)* | 1.85 (0.97 to 3.12) | 1.62 (0.98 to 2.64) | 1.36 (0.85 to 2.15) | 1.53 (0.90 to 2.47) | 1.33 (0.86 to 2.05) | 1.38 (0.91 to 2.13) | 2.27 (0.59 to 6.48) |
| Clop | 0.74 (0.37 to 1.49) | 3.62 (1.07 to 10.60)* | 1.00 | 1.28 (0.85 to 1.79) | 1.35 (0.75 to 2.15) | 1.18 (0.75 to 1.73) | 0.99 (0.70 to 1.32) | 1.12 (0.70 to 1.65) | 0.97 (0.74 to 1.23) | 1.01 (0.77 to 1.27) | 1.65 (0.43 to 4.39) |
| Dip | — | — | — | 1.00 | 1.07 (0.59 to 1.80) | 0.94 (0.58 to 1.50) | 0.79 (0.50 to 1.16) | 0.89 (0.52 to 1.41) | 0.77 (0.52 to 1.12) | 0.80 (0.58 to 1.12) | 1.32 (0.33 to 3.56) |
| Sarp | 0.88 (0.23 to 2.32) | 4.44 (0.78 to 14.55) | 1.32 (0.27 to 3.90) | — | 1.00 | 0.93 (0.49 to 1.64) | 0.78 (0.43 to 1.28) | 0.88 (0.46 to 1.50) | 0.76 (0.42 to 1.29) | 0.79 (0.44 to 1.27) | 1.30 (0.31 to 3.68) |
| Teru | 1.27 (0.53 to 2.45) | 6.15 (1.55 to 16.85)* | 1.94 (0.56 to 4.37) | — | 2.06 (0.41 to 6.21) | 1.00 | 0.87 (0.53 to 1.28) | 0.98 (0.57 to 1.57) | 0.85 (0.56 to 1.24) | 0.88 (0.59 to 1.31) | 1.44 (0.35 to 3.83) |
| Tic | 0.96 (0.39 to 2.02) | 4.71 (1.09 to 14.72)* | 1.43 (0.46 to 3.34) | — | 1.60 (0.31 to 5.17) | 0.87 (0.28 to 2.19) | 1.00 | 1.14 (0.75 to 1.75) | 0.99 (0.71 to 1.37) | 1.03 (0.75 to 1.43) | 1.67 (0.47 to 4.38) |
| Trif | 0.68 (0.18 to 1.72) | 3.23 (0.59 to 10.75) | 1.02 (0.20 to 2.89) | — | 1.09 (0.15 to 3.94) | 0.65 (0.13 to 1.67) | 0.83 (0.16 to 2.62) | 1.00 | 0.90 (0.56 to 1.35) | 0.93 (0.63 to 1.34) | 1.53 (0.37 to 3.93) |
| Asp+Clop | 1.31 (0.67 to 2.46) | 6.45 (1.72 to 19.79)* | 1.91 (0.94 to 3.50) | — | 2.11 (0.48 to 6.08) | 1.18 (0.42 to 2.87) | 1.63 (0.52 to 3.90) | 2.72 (0.66 to 7.90) | 1.00 | 1.05 (0.78 to 1.40) | 1.73 (0.45 to 4.73) |
| Asp+Dip | 0.85 (0.46 to 1.37) | 4.17 (1.20 to 11.06)* | 1.25 (0.55 to 2.03) | — | 1.38 (0.32 to 3.81) | 0.77 (0.26 to 1.78) | 1.05 (0.34 to 2.30) | 1.74 (0.42 to 5.12) | 0.70 (0.29 to 1.32) | 1.00 | 1.65 (0.45 to 4.21) |
| Asp+Tic | — | — | — | — | — | — | — | — | — | — | 1.00 |
Each cell gives an odds ratio (OR) and 95% credible interval. In the upper diagonal part, the OR compares the column condition with the row condition, and in the lower diagonal part, this OR compares the row condition with the column condition. Asp indicates aspirin; Cilo, cilostazol; Clop, clopidogrel; Dip, dipyridamole; NS, not specified; Sarp, sarpogrelate; Teru, terutroban; Tic, ticlopidine; Trif, triflusal.
*
Significant results.